U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8358183581A Pilot Study to Evaluate Safety and Performance of Neuromuscular Electrical Stimulation With the Inko RS Device for the Treatment of Stress Urinary IncontinenceCompletedNo Results AvailableStress Urinary IncontinenceDevice: Inko RS Devicehttps://ClinicalTrials.gov/show/NCT01472068
8358283582Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell TransplantationRecruitingNo Results AvailableAcute Leukemia|Chronic Leukemia|Severe Aplastic AnemiaDrug: Fludarabinehttps://ClinicalTrials.gov/show/NCT01472055
8358383583A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student AthletesRecruitingNo Results AvailableTraumatic Brain Injury|Sports Concussion|Sports InjuryOther: Banyan Biomarkershttps://ClinicalTrials.gov/show/NCT01472042
8358483584Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or StomachActive, not recruitingNo Results AvailableAdenocarcinoma of the Gastroesophageal Junction|Adenocarcinoma of the StomachDrug: 5-FU, leucovorin, docetaxel, oxaliplatin (FLOT), trastuzumab|Drug: Post-operative treatment trastuzumab mono therapyhttps://ClinicalTrials.gov/show/NCT01472029
8358583585Study of ABT-700 in Subjects With Advanced Solid TumorsActive, not recruitingNo Results AvailableAdvanced Solid TumorsDrug: ABT-700|Drug: docetaxel|Drug: FOLFIRI|Drug: cetuximab|Drug: erlotinib|Drug: ABT-700https://ClinicalTrials.gov/show/NCT01472016
8358683586An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor TypesCompletedNo Results AvailableAdvanced Solid TumorsDrug: ABT-806|Drug: ABT-806ihttps://ClinicalTrials.gov/show/NCT01472003
8358783587Effect of PACAP38/VIP on Migraineurs Measured by Magnetic ResonanceCompletedNo Results AvailableMigraine Without AuraDrug: Pituitary Adenylate Cyclase-Activating Polypeptide-38|Drug: Vasoactive Intestinal Peptidehttps://ClinicalTrials.gov/show/NCT01471990
8358883588Treatment Adherence of Tuberculosis MedicinesCompletedNo Results AvailableTuberculosisOther: education,counseling, default tracers,quality of carehttps://ClinicalTrials.gov/show/NCT01471977
8358983589Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung CancerRecruitingNo Results AvailableNon-small Cell Lung Cancer Metastatic|Non-small Cell Lung Cancer RecurrentDrug: MLN8237 and Erlotinibhttps://ClinicalTrials.gov/show/NCT01471964
8359083590Single Human Embryo Transfer in Assisted Reproduction ProgramsRecruitingNo Results AvailableMultiple PregnanciesOther: Single embryo transfer in women at risk of multiple pregnancieshttps://ClinicalTrials.gov/show/NCT01471951
8359183591Application and Adaption of Device Specific Body Composition Formulas to Various Ethnic GroupsCompletedNo Results AvailableBioelectrical Impedance Measurement of Healthy Adultshttps://ClinicalTrials.gov/show/NCT01471938
8359283592Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBICWithdrawnNo Results AvailableGastroesophageal Reflux DiseaseDrug: Nexium®|Drug: Esomeprazol (40mg) + Sdium Bicarbonate (721mg)https://ClinicalTrials.gov/show/NCT01471925
8359383593Elongation of Foveal Tissue After Macular Hole SurgeryCompletedNo Results AvailableMacular HolesProcedure: pars plana vitrectomy and fluid gas exchangehttps://ClinicalTrials.gov/show/NCT01471912
8359483594Comparison Of Ketorolac Tromethamine Oral Drops Versus Naproxen For Moderate to Severe Back Pain TreatmentNot yet recruitingNo Results AvailableBack PainDrug: Ketorolac Tromethamine|Drug: Naproxenhttps://ClinicalTrials.gov/show/NCT01471899
8359583595Comparison Of Ketorolac Tromethamine Versus Naproxen For Moderate to Severe Back Pain TreatmentRecruitingNo Results AvailableBack PainDrug: Ketorolac Tromethamine|Drug: Naproxenhttps://ClinicalTrials.gov/show/NCT01471886
8359683596Variability of Pentacam-derived Back Elevation Measurements in Keratoconus and Cross-linked CorneasCompletedNo Results AvailableKeratoconusProcedure: Corneal Collagen Cross-linking (CXL)https://ClinicalTrials.gov/show/NCT01471873
8359783597Barostim Neo System in the Treatment of Heart FailureActive, not recruitingNo Results AvailableHeart FailureDevice: Barostim Neo Systemhttps://ClinicalTrials.gov/show/NCT01471860
8359883598A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to TrastuzumabCompletedNo Results AvailableLocally Advance Breast Cancer (LABC)|Metastatic Breast Cancer (MBC)Drug: BEZ235 + Trastuzumab Phase l/Phase ll)|Drug: Lapatinib + Capecitabine (Phase II)https://ClinicalTrials.gov/show/NCT01471847
8359983599Barostim Neo System in the Treatment of Resistant HypertensionActive, not recruitingNo Results AvailableHigh Blood PressureDevice: Barostim Neo Systemhttps://ClinicalTrials.gov/show/NCT01471834
8360083600Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral SuppressionCompletedNo Results AvailableHIV InfectionDrug: antiretroviral treatmenthttps://ClinicalTrials.gov/show/NCT01471821
8360183601Effects of Different Early Intensive Therapies on Long-term β-cell FunctionEnrolling by invitationNo Results AvailableDiabetes Mellitus, Type 2Drug: CSII|Drug: CSII, Metformin, Pioglitazone|Drug: CSII, Sitagliptinhttps://ClinicalTrials.gov/show/NCT01471808
8360283602The Epidemiology of Ventricular Assist Device-Related InfectionsCompletedNo Results AvailableCongestive Heart Failurehttps://ClinicalTrials.gov/show/NCT01471795
8360383603Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaActive, not recruitingNo Results AvailableAcute Lymphoblastic LeukemiaDrug: blinatumomabhttps://ClinicalTrials.gov/show/NCT01471782
8360483604Video Education Intervention in the Emergency DepartmentCompletedNo Results AvailablePainBehavioral: Pain management video|Behavioral: Falls Prevention Videohttps://ClinicalTrials.gov/show/NCT01471769
8360583605Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal NeoplasiaCompletedNo Results AvailableNeoplasms|Gastric CancerProcedure: Standard of Care Procedure as described in ARMhttps://ClinicalTrials.gov/show/NCT01471756
8360683606GI Surgery Pre-Operative NutritionActive, not recruitingNo Results AvailableImmunonutritionDietary Supplement: Impact Advance Recovery (R)|Dietary Supplement: Ensure Plus (R)https://ClinicalTrials.gov/show/NCT01471743
8360783607The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac SurgeryCompletedNo Results AvailableHeart DiseaseDrug: Fibrinogen|Drug: Saline solution|Drug: Prothrombin complexhttps://ClinicalTrials.gov/show/NCT01471730
8360883608Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy SubjectsCompletedNo Results AvailableHealthyDrug: INX-08189 50 mg QD X 5 days|Drug: INX-08189 / Victrelis 800 mg TID X three days|Drug: Victrelis 800 mg TID x 3 days|Drug: Victrelis 800 mg TID with INX-08189 50 mg QD|Drug: Placebo with Victrelis 800 mg|Drug: Cohort 2: Victrelis 800 mg with Placebohttps://ClinicalTrials.gov/show/NCT01471717
8360983609Study Investigating the Pharmacokinetic Interaction Between INX-08189 and Verapamil HCL ER in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: INX-08189 50 mg|Drug: 240 mg verapamil HCL ER|Drug: 50 mg dose of INX-08189 and 240 mg verapamil HCL ERhttps://ClinicalTrials.gov/show/NCT01471704
8361083610Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving BevacizumabCompletedHas ResultsBranch Retinal Vein Occlusion|Central Retinal Vein Occlusion|Macular EdemaDrug: ranibizumab 0.5mg|Drug: ranibizumab 1.0mghttps://ClinicalTrials.gov/show/NCT01471691

* Görseller ve İçerik tekif hakkına sahip olabilir